[HTML][HTML] Insulin Resistance is an Integral Feature of MASLD Even in the Presence of PNPLA3 Variants
F Bril, S Kalavalapalli, R Lomonaco, R Frye, EG Leiva… - JHEP Reports, 2024 - Elsevier
Abstract Background & Aims It has been postulated that I148M carriers of PNPLA3 (CG
[Ile/Met] or GG [Met/Met]) develop MASLD in the absence of insulin resistance or metabolic …
[Ile/Met] or GG [Met/Met]) develop MASLD in the absence of insulin resistance or metabolic …
[HTML][HTML] Genotype-informed nutrition counselling in clinical practice
M Kohlmeier, E Baah, M Washko… - BMJ Nutrition, Prevention …, 2023 - ncbi.nlm.nih.gov
Many patients do not achieve the desired response to nutrition interventions because they
absorb, metabolise, excrete or regulate food constituents and derived molecules differently …
absorb, metabolise, excrete or regulate food constituents and derived molecules differently …